About: Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1999

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1999 (uk) article scientifique publié en 1999 (fr) im Juli 1999 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 1999 (ast) scientific article published on 01 July 1999 (en)
publication date	wds:Q77933868-72FF3370-FEBF-44AB-994C-43C63BC21566
publication date	1999-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q77933868-5257B153-1486-4816-B089-D983B59107FC
language of work or name	English
cites work	wds:Q77933868-0BBE5AE6-86EF-491A-9153-493960CFF635 wds:Q77933868-249AB950-079F-4786-A4EB-2A7D69C2CCD5 wds:Q77933868-32C2AE0E-B7C4-4D6E-970D-6E91F2D97D87 wds:Q77933868-44A5FB31-4F30-46B0-A795-D183CCEFC285 wds:Q77933868-4756D72B-3805-409B-AED4-222568EBAF4E wds:Q77933868-50C5BD1C-35A7-4633-838B-96427819FE41 wds:Q77933868-5D395689-8407-4C29-90AE-BEB62058BAB9 wds:Q77933868-5EB068C8-548E-4454-AC49-88388B021782 wds:Q77933868-64B98C93-57DA-4791-8B35-E5C4D15E4336 wds:Q77933868-68E9C67E-DF62-457D-A8A8-699AD1F0780A wds:Q77933868-77C8F289-0B69-4ACF-858F-4013417AE0B4 wds:Q77933868-8230ACF5-E88B-4D04-8A36-7676A94ABF43 wds:Q77933868-82DD79C8-EED2-4D32-92FA-AD2DEB51813A wds:Q77933868-83F77560-0CCE-4716-8BF4-B7A4417D7DA3 wds:Q77933868-866EFBC3-7159-4200-8E58-1F26429B1EEB wds:Q77933868-8AE22613-B4D0-417A-BC3F-0AD9722A70D8 wds:Q77933868-92AC3554-8F51-424E-BCD3-3DAFAFE52A2F wds:Q77933868-998E1BB9-10F0-45E2-B6DD-CC28DDB043F8 wds:Q77933868-A2EDD3C6-4BC0-4109-AD02-CFA36B96EB43 wds:Q77933868-A5C561D1-7C54-4C8D-B871-06A0B6261053 wds:Q77933868-ABBE14C4-66D1-47CD-8FBE-4CC76DE720E6 wds:Q77933868-BE08F084-23AC-4BE1-82AC-B052F1E77F91 wds:Q77933868-CEA5B427-B6D2-4BD4-9A1F-0DAB72A06DF8 wds:Q77933868-E696E5F3-FFCF-4337-B952-C5963701C172 wds:Q77933868-FA214F58-C1F4-4C26-BDF4-AE986BA7ACE0 wds:Q77933868-FA561FE0-45E9-4DF0-9524-2BC89C343F95
cites work	Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia. Impaired platelet-connective-tissue reaction in man after aspirin ingestion Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure Stroke Prevention in Atrial Fibrillation Study. Final results Epidemiologic features of chronic atrial fibrillation: the Framingham study The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study The natural history of lone atrial fibrillation. A population-based study over three decades Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls Preliminary report of the Stroke Prevention in Atrial Fibrillation Study Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion Coronary heart disease and atrial fibrillation: the Framingham Study Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study Platelet-aggregation response to single or paired aggregating stimuli after low-dose aspirin Multicentre European trials: their design, execution and relevance Current medical and surgical therapy for cerebrovascular disease Aspirin and myocardial infarction: is one positive study enough? Superior antiplatelet action of alternate day pulsed dosing versus split dose administration of aspirin Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study Effect of aspirin on coronary collateral blood flow Theory and practice in prevention of arterial thrombosis Aspirin and blood fibrinolysis
author name string	wds:Q77933868-2FD967D3-58BD-41B1-B74F-EAB5918B1807 wds:Q77933868-DF697C52-7869-4216-BB77-164343E9F079
author name string	V Barriales I S Posada
rdfs:label	Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group (en) Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group (nl)
skos:prefLabel	Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group (en) Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group (nl)
name	Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group (en) Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group (nl)
title	wds:Q77933868-744DD396-8D93-4130-B9FF-A4FFD1303955
title	Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group (en)
page(s)	wds:Q77933868-ACC821DE-7D37-45BD-B6CB-7247733FD59C
page(s)	137-143
instance of	wds:Q77933868-88572AEA-E82C-4733-AE28-DFE72A20FA5B
instance of	scholarly article
main subject	wds:Q77933868-51401584-2E45-4FA7-85FB-8D7CB918657E wds:Q77933868-BF32FEC9-D53B-4B56-9BE5-CC3FA1B44CAA
main subject	aspirin atrial fibrillation
PubMed ID	wds:Q77933868-B85B49E2-1B85-4EA3-B9BE-528D33BD88DD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10385777
PubMed ID	10385777
published in	wds:Q77933868-3EC0A79C-16F3-4340-BB1E-8482275B3392
published in	American Heart Journal
issue	wds:Q77933868-33FB34CC-6710-4746-A183-9738AD767F64
volume	wds:Q77933868-DED4ADF9-91DC-4822-8671-0194F6B5FD67
issue	1 Pt 1
volume	138
DOI	wds:Q77933868-6CAD936D-214C-4222-9EA9-BA758B7DA617
DOI	http://dx.doi.org/10.1016/S0002-8703(99)70259-0
DOI	10.1016/S0002-8703(99)70259-0
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q77933868
is cites work of	Direct thrombin inhibitors: novel antithrombotics on the horizon in the thromboprophylactic management of atrial fibrillation Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software